Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120.

Cleghorn F, Pape JW, Schechter M, Bartholomew C, Sanchez J, Jack N, Metch BJ, Hansen M, Allen M, Cao H, Montefiori DC, Tomaras GD, Gurunathan S, Eastman DJ, do Lago RF, Jean S, Lama JR, Lawrence DN, Wright PF; 026 Protocol Team and the NIAID HIV Vaccine Trials Network.

J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):222-30.

PMID:
17693888
2.

Development of a single-shot subunit vaccine for HIV-1. 5. programmable in vivo autoboost and long lasting neutralizing response.

Cleland JL, Lim A, Daugherty A, Barron L, Desjardin N, Duenas ET, Eastman DJ, Vennari JC, Wrin T, Berman P, Murthy KK, Powell MF.

J Pharm Sci. 1998 Dec;87(12):1489-95.

PMID:
10189254
3.

Genetic and immunologic characterization of viruses infecting MN-rgp120-vaccinated volunteers.

Berman PW, Gray AM, Wrin T, Vennari JC, Eastman DJ, Nakamura GR, Francis DP, Gorse G, Schwartz DH.

J Infect Dis. 1997 Aug;176(2):384-97.

PMID:
9237703
4.

Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1.

Berman PW, Murthy KK, Wrin T, Vennari JC, Cobb EK, Eastman DJ, Champe M, Nakamura GR, Davison D, Powell MF, Bussiere J, Francis DP, Matthews T, Gregory TJ, Obijeski JF.

J Infect Dis. 1996 Jan;173(1):52-9.

PMID:
8537682
5.

Effect of adjuvants on immunogenicity of MN recombinant glycoprotein 120 in guinea pigs.

Powell MF, Eastman DJ, Lim A, Lucas C, Peterson M, Vennari J, Weissburg RP, Wrin T, Kensil CR, Newman MJ, et al.

AIDS Res Hum Retroviruses. 1995 Feb;11(2):203-9.

PMID:
7742035
6.

Comparison of the immune response to recombinant gp120 in humans and chimpanzees.

Berman PW, Eastman DJ, Wilkes DM, Nakamura GR, Gregory TJ, Schwartz D, Gorse G, Belshe R, Clements ML, Byrn RA.

AIDS. 1994 May;8(5):591-601.

PMID:
7520248
7.

Development of a single-shot subunit vaccine for HIV-1.

Cleland JL, Powell MF, Lim A, BarrĂ³n L, Berman PW, Eastman DJ, Nunberg JH, Wrin T, Vennari JC.

AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S21-6.

PMID:
7865303
8.

Immunogenicity and HIV-1 virus neutralization of MN recombinant glycoprotein 120/HIV-1 QS21 vaccine in baboons .

Powell MF, Cleland JL, Eastman DJ, Lim A, Murthy K, Newman MJ, Nunberg JH, Weissburg RP, Vennari JC, Wrin T, et al.

AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S105-8. Erratum in: AIDS Res Hum Retroviruses 1995 May;11(5):661.

PMID:
7865282
9.

Monoclonal antibodies to the extracellular domain of HIV-1IIIB gp160 that neutralize infectivity, block binding to CD4, and react with diverse isolates.

Nakamura GR, Byrn R, Rosenthal K, Porter JP, Hobbs MR, Riddle L, Eastman DJ, Dowbenko D, Gregory T, Fendly BM, et al.

AIDS Res Hum Retroviruses. 1992 Nov;8(11):1875-85.

PMID:
1283308
10.

Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1.

Berman PW, Matthews TJ, Riddle L, Champe M, Hobbs MR, Nakamura GR, Mercer J, Eastman DJ, Lucas C, Langlois AJ, et al.

J Virol. 1992 Jul;66(7):4464-9.

Supplemental Content

Loading ...
Support Center